Orexigen Therapeutics, Inc. (OREX) Stock News, Earnings & History

(NASDAQ:OREX) Healthcare

Enjoy Interactive Tools and Indicators

52wk high: 7.73
52wk low: 3.10
EPS: -1.29
P/E: N/A
Div Rate: N/A
Yield: N/A
Market Cap: 613.28M
Avg Vol (3m): 1.12M

Insider Trading Cheat Sheet

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Booth Mark D Chief Commercial Officer Mar 11 Option Exercise 1.66 27,685 45,957 27,685 Mar 12 08:26 PM
Booth Mark D Chief Commercial Officer Mar 11 Sale 6.67 27,685 184,659 0 Mar 12 08:26 PM
Booth Mark D Chief Commercial Officer Jan 15 Option Exercise 1.66 22,315 37,043 22,315 Jan 18 06:02 AM
Booth Mark D Chief Commercial Officer Jan 15 Sale 6.67 22,315 148,842 0 Jan 18 06:02 AM
Turner Heather D SVP, Gen. Counsel & Secretary Jul 17 Option Exercise 1.66 82,433 136,839 82,433 Jul 19 07:59 PM
NARACHI MICHAEL President and CEO Jul 17 Option Exercise 1.67 150,000 250,030 124,238 Jul 19 08:07 PM
NARACHI MICHAEL President and CEO Jul 17 Sale 7.66 150,000 1,149,000 0 Jul 19 08:07 PM
Turner Heather D SVP, Gen. Counsel & Secretary Jul 17 Sale 7.68 82,433 633,448 0 Jul 19 07:59 PM
NARACHI MICHAEL President and CEO Jul 13 Option Exercise 1.66 147,100 244,186 147,100 Jul 13 08:13 PM
Hagan Joseph P Chief Business Officer Jul 13 Option Exercise 1.66 30,000 49,800 30,000 Jul 13 08:13 PM
Yahoo, HV, Market Watch, The Wall St. Journal